SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults · Study

ArticleShelves

ArticlePharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Randall Brown2017

Article2017

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Randall Brown · Christopher R. N. Nicholas · Nicholas V. Cozzi · Michele Gassman · Chantelle Thomas · Scott Hetzel +3 more

188 citations·0/0 files stored·Clinical Pharmacokinetics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Psychedelics and Drug Studies Pharmacogenetics and Drug Metabolism Forensic Toxicology and Drug Analysis

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 188 citations exist upstream.

References

2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial 2016Psychedelics 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial 1992The Structured Clinical Interview for DSM-III-R (SCID)2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study 2004Hallucinogens 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer 2008Human hallucinogen research: guidelines for safety

Cited by

2021Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects 2021Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience 2018DARK Classics in Chemical Neuroscience: Psilocybin 2017Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2018Unifying Theories of Psychedelic Drug Effectsreview · 12 shared references 2017Modern Clinical Research on LSDreview · 11 shared references 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismsreview · 11 shared references 2016Clinical applications of hallucinogens: A review.article · 10 shared references 2021Dose–response relationships of psilocybin-induced subjective experiences in humansreview · 10 shared references 2018High dose psilocybin is associated with positive subjective effects in healthy volunteersarticle · 10 shared references

Details

Year2017

Typearticle

Published2017-03-28

VenueClinical Pharmacokinetics

ISSN-L0312-5963

Languageen

Citations188

Files0 public / 0

ShelfPsychedelics and Drug Studies

Identifiers

doi10.1007/s40262-017-0540-6

openalex_workW2600624779

Links

Imported from OpenAlex (CC0) — nothing here is generated.

2022Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants

2018Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition

2022Therapeutic use of psilocybin: Practical considerations for dosing and administration

2024Acute Adverse Effects of Therapeutic Doses of Psilocybin